Central Giant Cell Granuloma in Pediatric Patient
Zea Zagreb1*, Contreras William2 and Ixcó Marvin3
1 Department of Estomatología, Oral and Maxillofacial Surgery Unit, Hospital Roosevelt, Guatemala City, Guatemala.
2 Oral Maxillofacial Pathologyst, Universidad de San Carlos, Quetzaltenango, Guatemala.
3 Private practice, Jalapa city, Guatemala.
*Corresponding Author: Zagreb Zea, Department of Estomatología, Oral Maxillofacial Surgery, Hospital Roosevelt, Guatemala City, Guatemala.
DOI: https://doi.org/10.58624/SVOADE.2023.04.0134
Received: May 16, 2023 Published: May 25, 2023
Abstract
Central Giant Cell Granuloma (CGCG) is an osteolytic and expansile lesion of the mandible. This lesion affects a younger type of patients which generally require surgical treatment and hospitalization affecting vital structures and causing grow defects. We present a case in a 7-year-old patient using intralesional injections of triamcinolone acetonide. After such a treatment we observed new bone formation and reduction in the size of the lesion which derived in a great outcome in such a young patient. This treatment bypassed any required hospitalization or aggressive surgery reducing postoperative morbidity. This paper report successful treatment of intralesional administration of triamcinolone acetonide in a 7-year-old patient.
Keywords: Central Giant Cell Granuloma; triamcinolone acetonide; intralesional; infiltration.
Citation: Zagreb Z, William C, Marvin I. Central Giant Cell Granuloma in Pediatric Patient. SVOA Dentistry 2023, 4:3, 97-101.
